Valérie‐Jeanne Bardou

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

Valérie‐Jeanne Bardou, Grazia Arpino, Richard Elledge et al. · Journal of Clinical Oncology · 2003 · 748 citations

Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis

Jocelyne Jacquemier, Christophe Ginestier, Jacques Rougemont et al. · Cancer Research · 2005 · 212 citations · Full text

Breast Oncology, Engineering, Pathology +17

Immunophenotypic analysis of inflammatory breast cancers: identification of an ‘inflammatory signature’

Emmanuelle Charafe‐Jauffret, Carole Tarpin, Valérie‐Jeanne Bardou et al. · The Journal of Pathology · 2004 · 198 citations

WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type

Françoise Ugolini, Emmanuelle Charafe‐Jauffret, Valérie‐Jeanne Bardou et al. · Oncogene · 2001 · 176 citations

Medullary Type, Breast Oncology, Medicine +9

A Recurrent Chromosome Breakpoint in Breast Cancer at the <b> <i>NRG1</i> </b> / <b> <i>Neuregulin 1</i> </b> / <b> <i>Heregulin</i> </b> Gene

Huai-En Huang, Suet‐Feung Chin, Christophe Ginestier et al. · Cancer Research · 2004 · 91 citations